Literature DB >> 34254894

Landscape and progress of global COVID-19 vaccine development.

Hui-Yao Huang1, Shu-Hang Wang1, Yu Tang1, Wei Sheng2, Chi-Jian Zuo3, Da-Wei Wu1, Hong Fang1, Qiong Du4, Ning Li1.   

Abstract

The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected billions of lives globally, and the world hopes to end this epidemic by effective vaccination. In this review, we depict the latest panorama of global COVID-19 vaccine research and development based on different technology platforms, and summarize key characteristics and available evidence on vaccines authorized for emergency use, in order to provide insights into improve coordination in the COVID-19 outbreak response for related stakeholders.

Entities:  

Keywords:  COVID-19; Clinical trial; lanscape; vaccine

Year:  2021        PMID： 34254894     DOI： 10.1080/21645515.2021.1945901

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  11 in total

1.  A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants.

Authors:  Rui Wang; Chunyun Sun; Juan Ma; Chulin Yu; Desheng Kong; Meng Chen; Xuejie Liu; Dandan Zhao; Shuman Gao; Shuyuan Kou; Lili Sun; Zeyong Ge; Jun Zhao; Kuokuo Li; Tao Zhang; Yanjing Zhang; Chunxia Luo; Xuefeng Li; Yang Wang; Liangzhi Xie
Journal:  Vaccines (Basel)       Date:  2022-04-29

2.  Pyronaridine Protects against SARS-CoV-2 Infection in Mouse.

Authors:  Ana C Puhl; Giovanni F Gomes; Samara Damasceno; Andre S Godoy; Gabriela D Noske; Aline M Nakamura; Victor O Gawriljuk; Rafaela S Fernandes; Natalia Monakhova; Olga Riabova; Thomas R Lane; Vadim Makarov; Flavio P Veras; Sabrina S Batah; Alexandre T Fabro; Glaucius Oliva; Fernando Q Cunha; José C Alves-Filho; Thiago M Cunha; Sean Ekins
Journal:  ACS Infect Dis       Date:  2022-05-24       Impact factor: 5.578

3.  Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus.

Authors:  Claudia Almendárez-Rodriguez; Karla I Solis-Andrade; Dania O Govea-Alonso; Mauricio Comas-Garcia; Sergio Rosales-Mendoza
Journal:  Int J Biol Macromol       Date:  2022-06-08       Impact factor: 8.025

4.  The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development-A Systematic Review.

Authors:  Marcin Goławski; Piotr Lewandowski; Iwona Jabłońska; Marcin Delijewski
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

5.  Immune-mediated liver injury following COVID-19 vaccination: A systematic review.

Authors:  Akash Roy; Nipun Verma; Surender Singh; Pranita Pradhan; Sunil Taneja; Meenu Singh
Journal:  Hepatol Commun       Date:  2022-05-04

6.  Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.

Authors:  Irina Isakova-Sivak; Ekaterina Stepanova; Victoria Matyushenko; Sergei Niskanen; Daria Mezhenskaya; Ekaterina Bazhenova; Elena Krutikova; Tatiana Kotomina; Polina Prokopenko; Bogdan Neterebskii; Aleksandr Doronin; Elena Vinogradova; Kirill Yakovlev; Konstantin Sivak; Larisa Rudenko
Journal:  Vaccines (Basel)       Date:  2022-07-18

7.  Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice.

Authors:  Ana C Puhl; Giovanni F Gomes; Samara Damasceno; Ethan J Fritch; James A Levi; Nicole J Johnson; Frank Scholle; Lakshmanane Premkumar; Brett L Hurst; Felipe Lee-Montiel; Flavio P Veras; Sabrina S Batah; Alexandre T Fabro; Nathaniel J Moorman; Boyd L Yount; Rebekah J Dickmander; Ralph S Baric; Kenneth H Pearce; Fernando Q Cunha; José C Alves-Filho; Thiago M Cunha; Sean Ekins
Journal:  ACS Omega       Date:  2022-08-29

8.  Tea crude extracts effectively inactivate severe acute respiratory syndrome coronavirus 2.

Authors:  K Ishimoto; N Hatanaka; S Otani; S Maeda; B Xu; M Yasugi; J E Moore; M Suzuki; S Nakagawa; S Yamasaki
Journal:  Lett Appl Microbiol       Date:  2021-11-05       Impact factor: 2.813

9.  Global landscape of COVID-19 vaccination progress: insight from an exploratory data analysis.

Authors:  Samrat Kumar Dey; Md Mahbubur Rahman; Umme Raihan Siddiqi; Arpita Howlader; Md Arifuzzaman Tushar; Atika Qazi
Journal:  Hum Vaccin Immunother       Date:  2022-01-20       Impact factor: 3.452

10.  COVID-19 Vaccination within the Context of Reactogenicity and Immunogenicity of ChAdOx1 Vaccine Administered to Teachers in Poland.

Authors:  Maria Ganczak; Marcin Korzeń; Ewa Sobieraj; Jakub Goławski; Oskar Pasek; Daniel Biesiada
Journal:  Int J Environ Res Public Health       Date:  2022-03-06       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.